高い自然背景放射線領域:単一用量での体系的な適応反応を明らかにする文献レビュー
Juliette Restier-Verlet1, Clément Devic2, Camelia Bellemou1
1U1296 Unit (Radiation: Defense, Health and Environment), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.
Dose-response : a publication of International Hormesis Society
|September 4, 2025
まとめ
高い自然背景放射線領域 (HBRA) に住む人々は,継続的な低用量放射線にもかかわらず,有害な健康効果を示さない. 細胞は高濃度の放射線に対して 適応反応を示し タンパク質の移動メカニズムによって説明されます
科学分野:
- 環境科学
- 放射線生物学
- 遺伝学
背景:
- 自然背景放射は 世界的な健康問題です
- 地球の様々な地域では 放射能のレベルが大きく変化します
- 高い自然背景放射線領域 (HBRA) は,ユニークな被曝シナリオを示しています.
研究 の 目的:
- HBRAで継続的な低用量放射線による健康への影響を調査する.
- 世界的に主要なHBRAのデータを分析する.
- 慢性的で急性的な放射線被曝に対する 細胞の反応を理解するために
主な方法:
- HBRAに関する98件の研究 (1973年−2023年) の系統的レビュー.
- HBRAホットスポットにおける放射線量と住民の平均被曝量の比較
- HBRAとHBRA以外の集団における細胞エンドポイント (DNA破裂,癌,老化) の分析.
- 高用量放射線に対するex vivoリンパ球反応の評価
主要な成果:
- HBRAの住民はホットスポット評価よりも低い用量 (例えば,ラムサールでは80 mSv/年対260 mSv/年) を受ける.
- HBRAとHBRA以外のグループでは,DNA破裂,がん発生率,または老化における有意な差異は認められなかった.
- HBRA患者からのex vivoリンパ球は,高用量放射線 (0. 25 - 4Gy) に対して一貫して適応反応を示した.
結論:
- HBRAで継続的な低用量放射線被曝は,観察可能な有害な健康効果をもたらしません.
- HBRA集団は,より高い放射線量に対する保護的適応反応を示します.
- 放射能によるATMタンパク質の核移動は,これらの観察に機械的な説明を提供します.
関連する概念動画
Biological Effects of Radiation
15.9K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.9K
Dose-Response Relationship: Overview
3.6K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.6K
Dose-Response Relationship: Selectivity and Specificity
8.0K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
8.0K
Dose-Response Relationship: Potency and Efficacy
5.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.1K
Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173


